US HB5133 | 2019-2020 | 116th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on November 18 2019 - 25% progression, died in chamber
Action: 2020-12-24 - Placed on the Union Calendar, Calendar No. 578.
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on November 18 2019 - 25% progression, died in chamber
Action: 2020-12-24 - Placed on the Union Calendar, Calendar No. 578.
Text: Latest bill text (Introduced) [PDF]
Summary
Prohibits, subject to certain exceptions, the practice of product hopping, which is presumed when a drug manufacturer obtains removal of a drug from the Food and Drug Administration's approved drug list, discontinues a drug, or markets a reformulation of an already approved drug during a certain period after which the manufacturer has been notified that a competing drug manufacturer has applied for generic drug approval.
Title
Affordable Prescriptions for Patients Through Promoting Competition Act of 2019
Sponsors
| Rep. David Cicilline [D-RI] | Rep. Doug Collins [R-GA] | Rep. Jerrold Nadler [D-NY] | Rep. James Sensenbrenner [R-WI] |
| Rep. Lucy McBath [D-GA] | Rep. Ben Cline [R-VA] |
History
| Date | Chamber | Action |
|---|---|---|
| 2020-12-24 | House | Placed on the Union Calendar, Calendar No. 578. |
| 2020-12-24 | House | Reported by the Committee on Judiciary. H. Rept. 116-695. |
| 2019-11-21 | House | Ordered to be Reported. |
| 2019-11-21 | House | Committee Consideration and Mark-up Session Held. |
| 2019-11-19 | House | Subcommittee on Antitrust, Commercial, and Administrative Law Discharged. |
| 2019-11-18 | House | Referred to the House Committee on the Judiciary. |
| 2019-11-18 | House | Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law. |
| 2019-11-18 | House | Introduced in House |
Same As/Similar To
HB4398 (Related) 2019-10-02 - Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
SB1416 (Related) 2019-06-28 - Placed on Senate Legislative Calendar under General Orders. Calendar No. 132.
HB2486 (Related) 2020-07-23 - Message on House action received in Senate and at desk: House amendments to Senate amendment.
SB1416 (Related) 2019-06-28 - Placed on Senate Legislative Calendar under General Orders. Calendar No. 132.
HB2486 (Related) 2020-07-23 - Message on House action received in Senate and at desk: House amendments to Senate amendment.
Subjects
Administrative remedies
Civil actions and liability
Commerce
Competition and antitrust
Consumer affairs
Drug safety, medical device, and laboratory regulation
Federal Trade Commission (FTC)
Health care costs and insurance
Inflation and prices
Intellectual property
Judicial review and appeals
Manufacturing
Prescription drugs
Civil actions and liability
Commerce
Competition and antitrust
Consumer affairs
Drug safety, medical device, and laboratory regulation
Federal Trade Commission (FTC)
Health care costs and insurance
Inflation and prices
Intellectual property
Judicial review and appeals
Manufacturing
Prescription drugs
